DCK and familial pancreatic carcinoma: A novel finding of our study is the critical importance of DCK for gemcitabine sensitivity and thus any combination therapy using gemcitabine; pancreatic cancer cells without DCK are resistant to gemcitabine alone or in combination with entinostat.